Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 30 (23) , 127560
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family FunctionsTrends in Immunology, 2017
- Mechanism and Regulation of NLRP3 Inflammasome ActivationTrends in Biochemical Sciences, 2016
- MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s diseaseMolecular Neurodegeneration, 2016
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 miceNature, 2012
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesNature Immunology, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?Science, 2010
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- Glutathione S-Transferase Omega 1-1 Is a Target of Cytokine Release Inhibitory Drugs and May Be Responsible for Their Effect on Interleukin-1औ Posttranslational ProcessingJournal of Biological Chemistry, 2003
- The InflammasomeMolecular Cell, 2002